Analytical Test Methods Sample Clauses
The Analytical Test Methods clause defines the procedures and standards to be used for testing and analyzing materials, products, or processes under the agreement. It typically specifies which testing protocols, equipment, or industry standards must be followed, and may require that both parties agree on the methods or that a recognized third-party standard is used. This clause ensures consistency and reliability in test results, reducing disputes over quality or compliance by clearly establishing how analyses will be conducted and interpreted.
Analytical Test Methods. 4.1 Cardinal shall be responsible for demonstrating the suitability (methods transfer or validation, as appropriate) of all methodology used to release raw materials, components, and the finished product, as appropriate.
Analytical Test Methods. Patheon shall be responsible for demonstrating the validity of all methodology used for in-process control, and release of all materials, Active Compound, components and the Product. This validation, or verification in the case of a compendial raw material item, will be demonstrated. This validation shall be established, through approved protocol and final report, based on the current ICH and FDA validation guidance documents. Method validation shall be performed. Suitability of all compendia methodology will be demonstrated, and written in a report, prior to use for release of materials, Active Compound, components, or the Product(s).
Analytical Test Methods. 3.1 Shasun shall be responsible for demonstrating the validity of all methodology used for in-process control, and release of process materials, intermediates, and API. This validation shall be established, through approved protocol and final report, based on the current ICH and FDA validation guidance documents. Method validation shall be performed consistent with Shasun-approved procedures.
Analytical Test Methods. 3 .1 Abbott shall be responsible for demonstrating the validity of all methodology used for in-process control, and release of all materials, Active Compound, components and the Product. This validation, or verification in the case of a compendial raw material item, will be demonstrated. This validation shall be established, through approved protocol and final report, based on the current ICH and FDA validation guidance documents. Method validation shall be performed consistent with Abbott-approved procedures. . Suitability of all compendia methodology will be demonstrated, and written in a report, prior to use for release of materials, Active Compound, components, or the Product(s).